Andrea Colliva
Trieste, 34149, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Cardiomyocyte fusion contributes to cardiac hypertrophy in adult hearts.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 16, 2026
Anti-miRNA therapeutics for uterine fibroids.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 03, 2025
Endothelial-to-mesenchymal transition enhances permissiveness to AAV vectors in cardiac endothelial cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 14, 2024
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 30, 2023
Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation.
Journal: Stem cell research
Published: June 29, 2023
Flt1 produced by lung endothelial cells impairs ATII cell transdifferentiation and repair in pulmonary fibrosis.
Journal: Cell death & disease
Published: January 05, 2023
Ischemic wound revascularization by the stromal vascular fraction relies on host-donor hybrid vessels.
Journal: NPJ Regenerative medicine
Published: July 14, 2022
Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19.
Journal: The Journal of pathology
Published: July 13, 2022
Biologics and cardiac disease: challenges and opportunities.
Journal: Trends in pharmacological sciences
Published: March 23, 2022
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence.
Journal: Nature cell biology
Published: December 17, 2021
Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation.
Journal: Cell death & disease
Published: July 06, 2021
Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction.
Journal: Nature communications
Published: January 07, 2021
Last Updated: 09/26/2026